SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-002980
Filing Date
2023-01-06
Accepted
2023-01-06 07:30:56
Documents
13
Period of Report
2023-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d435443d8k.htm   iXBRL 8-K 24607
2 EX-2.1 d435443dex21.htm EX-2.1 102125
  Complete submission text file 0001193125-23-002980.txt   273847

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blue-20230105.xsd EX-101.SCH 2862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20230105_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20230105_pre.xml EX-101.PRE 10820
7 EXTRACTED XBRL INSTANCE DOCUMENT d435443d8k_htm.xml XML 3230
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 23513756
SIC: 2836 Biological Products, (No Diagnostic Substances)